Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Current Leases (2020 - 2025)

IceCure Medical (ICCM) has disclosed Current Leases for 5 consecutive years, with $298000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Current Leases rose 33.63% to $298000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $298000.0, a 33.63% increase, with the full-year FY2024 number at $298000.0, up 33.63% from a year prior.
  • Current Leases was $298000.0 for Q4 2024 at IceCure Medical, up from $223000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $298000.0 in Q4 2024 to a low of $167000.0 in Q4 2022.
  • A 5-year average of $225200.0 and a median of $223000.0 in 2023 define the central range for Current Leases.
  • Peak YoY movement for Current Leases: dropped 25.45% in 2022, then soared 33.63% in 2024.
  • IceCure Medical's Current Leases stood at $214000.0 in 2020, then rose by 4.67% to $224000.0 in 2021, then decreased by 25.45% to $167000.0 in 2022, then soared by 33.53% to $223000.0 in 2023, then soared by 33.63% to $298000.0 in 2024.
  • Per Business Quant, the three most recent readings for ICCM's Current Leases are $298000.0 (Q4 2024), $223000.0 (Q4 2023), and $167000.0 (Q4 2022).